Ranbaxy Laboratories: Announces Q2 results & Limited Review Report for the Quarter ended September 30, 2014

Ranbaxy Laboratories Ltd has announced the following results for the quarter ended September 30, 2014:

The Unaudited Standalone results for the Quarter ended September 30, 2014

The Company has posted a net loss of Rs. (3682.57) million for the quarter ended September 30, 2014 as compared to net loss of Rs. (8422.32) million for the quarter ended September 30, 2013. Total Income has decreased from Rs. 14701.86 million for the quarter ended September 30, 2013 to Rs. 13389.31 million for the quarter ended September 30, 2014.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended September 30, 2014

The Group has posted a net profit after tax, minority interest and share in profit of associates of Rs. 4777.56 million for the quarter ended September 30, 2014 as compared to net loss of Rs. (4541.69) million for the quarter ended September 30, 2013. Total Income has increased from Rs. 28277.34 million for the quarter ended September 30, 2013 to Rs. 32778.76 million for the quarter ended September 30, 2014.